Alessandro Didonna University of California, San Francisco
48 protocols

Olga Kopach Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, University College London, UK
2 protocols

Pooja Teotia University of Nebraska Medical Center
1 protocol

Doyel Sen
  • Research scientist, E-Scape Bio Inc
Research focus
  • Biochemistry
  • Neurodegenerative disorders, Assay Development, Drug screening


PhD, Rutgers, 2012

2 Protocols reviewed
A Parkinson’s Disease-relevant Mitochondrial and Neuronal Morphology High-throughput Screening Assay in LUHMES Cells

Parkinson’s disease is a devastating neurodegenerative disorder affecting 2-3% of the population over 65 years of age. There is currently no disease-modifying treatment. One of the predominant pathological features of Parkinson’s disease

More >
Inositol Phosphates Purification Using Titanium Dioxide Beads
Authors:  Miranda SC Wilson and Adolfo Saiardi, date: 08/05/2018, view: 3697, Q&A: 0
Inositol phosphates (IPs) comprise a family of ubiquitous eukaryotic signaling molecules. They have been linked to the regulation of a pleiotropy of important cellular activities, but low abundance and detection difficulties have hampered our ...
More >
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.